Related Experiment Video

Updated: Jun 3, 2025

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
10:01

Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation

Published on: July 10, 2012

20.3K

Dealing With Antibiotic Prophylaxis in Lung Transplantation in the Era of Multidrug Resistance: The Milano Algorithm

Andrea Lombardi1, Davide Mangioni2, Giulia Renisi2

  • 1Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Transplantation Proceedings
|January 9, 2025
PubMed

Insights

Infectious complications are a major threat after lung transplantation (LuTx). Multiplex PCR tests offer a promising approach for rapid pathogen identification and targeted antibiotic therapy to combat antimicrobial resistance (AMR).

Area of Science:

  • Medical Microbiology
  • Transplant Surgery
  • Infectious Diseases

Background:

  • Infectious complications are a leading cause of death post-lung transplantation (LuTx), accounting for over 25% of mortality.
  • Current antibiotic prophylaxis practices, particularly for multidrug-resistant organisms (MDROs), are inconsistent and contribute to antimicrobial resistance (AMR) concerns in immunocompromised patients.

Purpose of the Study:

  • To explore the potential of syndromic multiplex polymerase chain reaction (mPCR) tests in lung transplantation.
  • To evaluate the utility of mPCR for rapid pathogen and resistance mechanism identification to guide targeted antimicrobial therapy.

Main Methods:

  • Review of current practices in antibiotic prophylaxis for lung transplantation.
  • Discussion of the potential application and limitations of syndromic multiplex PCR (mPCR) in the LuTx setting.

Main Results:

  • Infectious complications significantly increase morbidity and mortality in lung transplant recipients.
  • Wide-spectrum antibiotic use raises concerns regarding antimicrobial resistance (AMR).
  • Syndromic mPCR tests can simultaneously detect multiple pathogens and resistance mechanisms, enabling faster, targeted treatments.

Conclusions:

  • Targeted antimicrobial therapy guided by rapid diagnostics like mPCR is crucial for managing infections in lung transplant recipients.
  • Further research and clinical integration of mPCR are needed to optimize outcomes and combat AMR in LuTx.
  • Addressing infectious complications through advanced diagnostics is vital for improving survival rates in lung transplantation.

More Related Videos

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

811
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.0K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177